Overview
This study aims to evaluate mid- and long-term outcomes after Thoracic endovascular aortic repair (TEVAR) with custom-made devices.
Eligibility
Inclusion Criteria:
- Thoracic Aortic Disease
Exclusion Criteria:
- Urgent/Emergent treatment
Mid- and Long-term Outcomes of Custom-made Aortic Devices
Recruiting
18
years of age
Both
Phase N/A
Study details
Aortic Diseases, Thoracic Aortic Aneurysm
NCT05777460
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
25 January 2024
Step
1
Get in touch with the nearest study center
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
A clinical trial is a study designed to test specific
interventions or treatments' effectiveness and safety,
paving the way for new, innovative healthcare solutions.
Why should I take part in a clinical trial?
Participating in a clinical trial provides early access to
potentially effective treatments and directly contributes to
the healthcare advancements that benefit us all.
How long does a clinical trial take place?
The duration of clinical trials varies. Some trials last
weeks, some years, depending on the phase and intention of
the trial.
Do I get compensated for taking part in clinical trials?
Compensation varies per trial. Some offer payment or
reimbursement for time and travel, while others may not.
How safe are clinical trials?
Clinical trials follow strict ethical guidelines and
protocols to safeguard participants' health. They are
closely monitored and safety reviewed regularly.
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.